MOUNTAIN VIEW, Calif.,
Feb. 13, 2017 /PRNewswire/ --
Omnicell, Inc. (NASDAQ: OMCL), a leading provider of medication and
supply management solutions and adherence tools for healthcare
systems and pharmacies, is pleased to showcase its recently
enhanced portfolio at the HIMSS17 Conference & Exhibition,
taking place February 19-23 in
Orlando. Through the single-server
Unity enterprise platform and interoperability with leading
electronic health record (EHR) vendors, Omnicell is committed to
streamlining clinical workflows while supporting the highest level
of medication security and patient safety.
Hospitals continue facing countless challenges, including rising
drug prices, reimbursement hurdles with value-based care
initiatives, and determining how to best utilize "big data" that
exists within their health system—all while continuing to make
excellent patient care a top priority.i As a result, the
healthcare industry is increasingly interested in analytics tools
as well as services that can help hospital leaders identify and
prioritize areas of inefficiency within their systems. Omnicell has
responded to these needs through new service and technology
offerings introduced late last year that help healthcare providers
navigate these challenges without placing undue burden on
clinicians.
Omnicell's solutions can be seen in booth #4009 and will feature
demonstrations of the interoperability between the Omnicell
medication dispensing system and Cerner and Epic EHRs. This
integration saves clinicians steps in medication workflow and helps
promote safety. The Remote Medication Queuing solution streamlines
the medication administration process for nursing, enabling more
time for patient care. Closed Loop Dose Accountability helps
minimize the risk of diversion while saving pharmacy and nursing
time spent reconciling controlled substances.
Also featured in the booth will be the following:
- The XT Series Automated Dispensing System offers a high degree
of flexibility to fit various medication distribution needs, and it
can easily expand and scale as health systems grow. Compared to
similar units on the market, Omnicell® XT Automated
Dispensing Cabinets offer 50 percent more capacity for medication
storage on hospital floors.
- Helping drive down costs and improve allocation of resources,
the Performance Center combines leading inventory analytics
software with a dedicated team of data scientists and professionals
to drive improvements in pharmacy operations. Early adopters have
seen a 20% average reduction in inventory levels and a 2% average
savings in annual medication spend, freeing up valuable resources
for other enterprise activities.
- Designed to help proactively detect drug diversion, Omnicell
Analytics is a web-based analytics tool that streamlines the
process of managing potential drug diversion across the health
system, helping to improve patient care and safety.
Omnicell's interoperability with Epic will also be demonstrated
in the Interoperability Showcase's Surgery & Recovery use case
in booth #9000, Hall F. A nurse will issue an infusion order for a
patient from the XT Automated Dispensing Cabinet and perform the
reconciliation post administration. Omnicell's Closed Loop Dose
Accountability will compare medications dispensed and/or wasted
from the Omnicell cabinet versus the documented administration in
the Epic EHR. This new integration automates manual tracking and
increases vigilance of controlled substances, helping to prevent
drug diversion.
"As we continue to transition to value-based care models, many
hospital leaders are challenged to do more with less without
compromising clinical care. Our goal is to enable health systems to
gain the most potential from their technology investments as they
balance these needs," said Joe
Lynch, vice president, Marketing at Omnicell. "We're excited
to return to HIMSS and showcase the technology and services we
offer our hospital and health system partners to tackle critical
challenges."
About Omnicell
Since 1992, Omnicell (NASDAQ: OMCL) has been inspired to create
safer and more efficient ways to manage medications and supplies
across all care settings. As a leader in medication and supply
dispensing automation, central pharmacy automation, IV robotics,
analytics software, and medication adherence and packaging systems,
Omnicell is focused on improving care across the entire healthcare
continuum—from the acute care hospital setting, to post-acute
skilled nursing and long-term care facilities, to the patient's
home.
Over 4,000 customers worldwide use Omnicell®
automation and analytics solutions to increase operational
efficiency, reduce medication errors, deliver actionable
intelligence and improve patient safety.
Omnicell's innovative medication adherence solutions, used by
over 32,000 institutional and retail pharmacies in North America and the United Kingdom, are designed to improve
patient adherence to prescriptions, helping to reduce costly
hospital readmissions.
Recent Omnicell acquisitions, including Ateb, add distinct
capabilities, particularly in central pharmacy, IV robotics, and
pharmacy software, creating the broadest medication management
product portfolio in the industry.
OMCL-G
Editor's Notes:
- All Omnicell news releases (financial, acquisitions, products,
technology etc.) are issued exclusively by PR Newswire and are
immediately thereafter posted on the company's external website,
omnicell.com.
- Omnicell and the Omnicell logo design are registered trademarks
of Omnicell, Inc.
- All other brand or product names may be trademarks or
registered trademarks of their respective companies.
i
http://www.healthcarefinancenews.com/news/top-10-healthcare-issues-watch-2016
[OR]
http://www.beckershospitalreview.com/hospital-management-administration/6-ceos-name-the-biggest-challenges-they-re-facing-today-and-5-years-out.html
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/omnicell-medication-management-solutions-and-interoperability-featured-at-himss17-with-real-world-application-in-interoperability-showcase-300406419.html
SOURCE Omnicell, Inc.